Biofrontera Pharmaceuticals Holding AG, DNAPrint deal

DNAP will invest E20 million ($24.5 million) over the next two years

Read the full 121 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE